Transesophageal echocardiography-associated tracheal microaspiration and ventilator-associated pneumonia in intubated critically ill patients: a multicenter prospective observational study.
Microaspiration
Pepsin
Salivary amylase
Transesophageal echocardiography
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
07 12 2020
07 12 2020
Historique:
received:
26
08
2020
accepted:
09
11
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
28
7
2021
Statut:
epublish
Résumé
Microaspiration of gastric and oropharyngeal secretions is the main causative mechanism of ventilator-associated pneumonia (VAP). Transesophageal echocardiography (TEE) is a routine investigation tool in intensive care unit and could enhance microaspiration. This study aimed at evaluating the impact of TEE on microaspiration and VAP in intubated critically ill adult patients. It is a four-center prospective observational study. Microaspiration biomarkers (pepsin and salivary amylase) concentrations were quantitatively measured on tracheal aspirates drawn before and after TEE. The primary endpoint was the percentage of patients with TEE-associated microaspiration, defined as: (1) ≥ 50% increase in biomarker concentration between pre-TEE and post-TEE samples, and (2) a significant post-TEE biomarker concentration (> 200 μg/L for pepsin and/or > 1685 IU/L for salivary amylase). Secondary endpoints included the development of VAP within three days after TEE and the evolution of tracheal cuff pressure throughout TEE. We enrolled 100 patients (35 females), with a median age of 64 (53-72) years. Of the 74 patients analyzed for biomarkers, 17 (23%) got TEE-associated microaspiration. However, overall, pepsin and salivary amylase levels were not significantly different between before and after TEE, with wide interindividual variability. VAP occurred in 19 patients (19%) within 3 days following TEE. VAP patients had a larger tracheal tube size and endured more attempts of TEE probe introduction than their counterparts but showed similar aspiration biomarker concentrations. TEE induced an increase in tracheal cuff pressure, especially during insertion and removal of the probe. We could not find any association between TEE-associated microaspiration and the development of VAP during the three days following TEE in intubated critically ill patients. However, our study cannot formally rule out a role for TEE because of the high rate of VAP observed after TEE and the limitations of our methods.
Sections du résumé
BACKGROUND
Microaspiration of gastric and oropharyngeal secretions is the main causative mechanism of ventilator-associated pneumonia (VAP). Transesophageal echocardiography (TEE) is a routine investigation tool in intensive care unit and could enhance microaspiration. This study aimed at evaluating the impact of TEE on microaspiration and VAP in intubated critically ill adult patients.
METHODS
It is a four-center prospective observational study. Microaspiration biomarkers (pepsin and salivary amylase) concentrations were quantitatively measured on tracheal aspirates drawn before and after TEE. The primary endpoint was the percentage of patients with TEE-associated microaspiration, defined as: (1) ≥ 50% increase in biomarker concentration between pre-TEE and post-TEE samples, and (2) a significant post-TEE biomarker concentration (> 200 μg/L for pepsin and/or > 1685 IU/L for salivary amylase). Secondary endpoints included the development of VAP within three days after TEE and the evolution of tracheal cuff pressure throughout TEE.
RESULTS
We enrolled 100 patients (35 females), with a median age of 64 (53-72) years. Of the 74 patients analyzed for biomarkers, 17 (23%) got TEE-associated microaspiration. However, overall, pepsin and salivary amylase levels were not significantly different between before and after TEE, with wide interindividual variability. VAP occurred in 19 patients (19%) within 3 days following TEE. VAP patients had a larger tracheal tube size and endured more attempts of TEE probe introduction than their counterparts but showed similar aspiration biomarker concentrations. TEE induced an increase in tracheal cuff pressure, especially during insertion and removal of the probe.
CONCLUSIONS
We could not find any association between TEE-associated microaspiration and the development of VAP during the three days following TEE in intubated critically ill patients. However, our study cannot formally rule out a role for TEE because of the high rate of VAP observed after TEE and the limitations of our methods.
Identifiants
pubmed: 33287866
doi: 10.1186/s13054-020-03380-w
pii: 10.1186/s13054-020-03380-w
pmc: PMC7719845
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
679Références
Am J Respir Crit Care Med. 1996 Jul;154(1):111-5
pubmed: 8680665
Intensive Care Med. 2010 Dec;36(12):2066-73
pubmed: 20852839
Ann Transl Med. 2017 Nov;5(22):444
pubmed: 29264361
Cochrane Database Syst Rev. 2016 Jan 08;(1):CD009946
pubmed: 26743945
Ann Transl Med. 2018 Jan;6(2):36
pubmed: 29430453
J Thorac Cardiovasc Surg. 1995 Aug;110(2):517-22
pubmed: 7637370
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1249-56
pubmed: 10194173
Curr Opin Pulm Med. 2009 May;15(3):230-5
pubmed: 19387351
Ann Transl Med. 2018 Nov;6(21):416
pubmed: 30581824
Crit Care Med. 2018 Jan;46(1):71-78
pubmed: 29053492
Intensive Care Med. 2017 Nov;43(11):1562-1571
pubmed: 28303301
JPEN J Parenter Enteral Nutr. 2004 Mar-Apr;28(2):79-84
pubmed: 15080601
Nurs Res. 2010 Jan-Feb;59(1):18-25
pubmed: 20010041
Am Rev Respir Dis. 1979 Sep;120(3):559-66
pubmed: 114074
Clin Chest Med. 1991 Sep;12(3):523-43
pubmed: 1934953
Crit Care. 2016 Oct 28;20(1):353
pubmed: 27788682
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Acta Anaesthesiol Scand. 2004 Aug;48(7):827-36
pubmed: 15242426
J Adv Nurs. 2019 Nov;75(11):3045-3057
pubmed: 31241194
Lancet Infect Dis. 2013 Aug;13(8):665-71
pubmed: 23622939
J Crit Care. 2016 Aug;34:95-102
pubmed: 27288618
Intensive Care Med. 2019 Jun;45(6):770-788
pubmed: 30911808
Crit Care Med. 2006 Apr;34(4):1007-15
pubmed: 16484901
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Infect Disord Drug Targets. 2011 Aug;11(4):413-23
pubmed: 21679139
N Engl J Med. 2001 Mar 1;344(9):665-71
pubmed: 11228282
Crit Care Med. 1995 Jul;23(7):1194-9
pubmed: 7600826
PLoS One. 2014 Mar 06;9(6):e90851
pubmed: 24603906
Crit Care Med. 2013 Mar;41(3):765-73
pubmed: 23314582
Am J Respir Crit Care Med. 2002 Apr 1;165(7):867-903
pubmed: 11934711
Minerva Anestesiol. 2013 Sep;79(9):1003-10
pubmed: 23652170
Chest. 2017 Oct;152(4):736-741
pubmed: 28694197
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1041-7
pubmed: 21836137
Infect Control Hosp Epidemiol. 2014 Aug;35(8):915-36
pubmed: 25026607
Crit Care Med. 2001 Aug;29(8):1495-501
pubmed: 11505114
JAMA. 1998 Mar 11;279(10):781-7
pubmed: 9508156
Intensive Care Med. 2010 Jul;36(7):1156-63
pubmed: 20397001